Gary Reedy
Gary M. Reedy, a seasoned leader, served as the CEO of the American Cancer Society and the American Cancer Society Cancer Action Network from 2015 to 2021, with 15 years of prior volunteer leadership within the organizations.
During his tenure, Reedy spearheaded a movement to combat cancer globally, emphasizing impactful initiatives in prevention, screening, and treatment to achieve a world without cancer.
His strategic leadership redefined the organization towards maximizing support for cancer progress, enhancing volunteer and customer experiences, promoting innovation, and advancing health equity.
Reedy set ambitious goals, including a 40% reduction in cancer mortality by 2035, and championed the Blueprint for Cancer Control in the 21st Century to guide the path to this objective.
Prior to his role at the American Cancer Society, Reedy held various senior positions at Johnson & Johnson, Ortho Biotech, SmithKline Beecham, and Centocor.
Reedy remains actively engaged with the American Cancer Society through multiple board appointments and advisory roles, showcasing his ongoing commitment to the organization and healthcare innovation.
He is an esteemed member of the Atlanta Rotary Club and has contributed significantly to various educational and healthcare institutions.
Gary Reedy is a graduate of Emory & Henry College with a Bachelor of Science in Biology and interdisciplinary minors in Chemistry and Physics. He also pursued executive education programs at UCLA, University of Tennessee, and Wharton.
With a distinguished career in healthcare and advocacy, Gary Reedy continues to make a profound impact in the fight against cancer and global health initiatives.
